Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | IONS | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 141.02 | 486.15 | 86.13 | ||
| High | 141.09 | 486.25 | 86.49 | ||
| Low | 138.50 | 469.69 | 84.61 | ||
| Latest | 139.56 | 473.12 | 84.79 | ||
| Change | -1.64 | -12.24 | -1.71 | ||
| % Change | -1.16% | -2.52% | -1.98% | ||
| Volume | 870,100 | 320,300 | 1,738,200 | ||
| 20-Day Average Volume | 1,029,885 | 337,485 | 2,330,655 | ||
| Previous Close | 141.20 | 485.36 | 86.50 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 135.99 | 473.93 | 81.58 | ||
| 20-Day Raw Stochastic | 80.08% | 51.64% | 84.45% | ||
| 20-Day Relative Strength | 50.39 | 47.28 | 57.97 | ||
| Weighted Alpha | +19.18 | +25.94 | +130.49 | ||
| Today's Opinion | 8% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 24% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.40% since 02/02/26 | -0.40% since 02/02/26 | +2.07% since 02/02/26 | ||
| Low | 136.46 on 02/05/26 | 469.69 on 02/09/26 | 82.54 on 02/04/26 | ||
| High | 142.15 on 02/06/26 | 489.50 on 02/06/26 | 86.74 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | +2.78% since 01/09/26 | -2.09% since 01/09/26 | +5.59% since 01/09/26 | ||
| Low | 129.17 on 01/20/26 | 455.63 on 01/20/26 | 74.20 on 01/20/26 | ||
| High | 142.15 on 02/06/26 | 489.50 on 02/06/26 | 86.74 on 02/05/26 | ||
| 3-Month | |||||
| %Chg | -8.41% since 11/07/25 | +5.39% since 11/07/25 | +15.28% since 11/07/25 | ||
| Low | 129.17 on 01/20/26 | 445.81 on 11/10/25 | 66.66 on 11/10/25 | ||
| High | 160.18 on 12/08/25 | 519.99 on 12/23/25 | 86.74 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | +11.64% since 08/08/25 | +56.92% since 08/08/25 | +103.63% since 08/08/25 | ||
| Low | 123.69 on 08/11/25 | 292.34 on 08/12/25 | 40.37 on 08/12/25 | ||
| High | 160.18 on 12/08/25 | 519.99 on 12/23/25 | 86.74 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,078,488 | 20,898,142 | 14,010,750 | ||
| Shares Outstanding, K | 99,706 | 43,057 | 161,974 | ||
| Annual Sales | 2,355,300,000 | 2,877,400,000 | 705,140,000 | ||
| Annual Net Income | 341,300,000 | 1,195,100,000 | -453,900,000 | ||
| Last Quarter Sales | 794,900,000 | 799,500,000 | 156,720,000 | ||
| Last Quarter Net Income | 209,500,000 | 338,700,000 | -128,610,000 | ||
| 60-Month Beta | 0.31 | 0.85 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 10/28/25 | 7.16 on 10/29/25 | -0.61 on 10/29/25 | ||
| Latest Earnings Date | 02/11/26 | 02/25/26 | 02/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 33.00 | 18.15 | 0.00 | ||